Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-08-18 5:00 pm Purchase | 13G | PALISADE BIO INC PALI | Lind Global Fund II LP | 4,000,000 6.2% | 4,000,000 (New Position) | View |
2022-08-05 5:23 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 3,666,750 9.9% | 3,232,439 (+744.27%) | View |
2022-07-22 5:00 pm Purchase | 13G | PERFORMANCE SHIPPING INC N PSHG | Lind Global Fund II LP | 1,400,000 5.1% | 1,400,000 (New Position) | View |
2022-07-13 5:00 pm Purchase | 13G | STAFFING 360 SOLUTIONS INC STAF | Lind Global Fund II LP | 117,769 5.4% | 117,769 (New Position) | View |
2022-07-12 5:00 pm Purchase | 13G | AGILE THERAPEUTICS INC AGRX | Lind Global Fund II LP | 3,250,223 9.9% | 3,250,223 (New Position) | View |
2022-06-08 5:00 pm Purchase | 13G | ENERGY FOCUS, INC PAR EFOI | Lind Global Fund II LP | 802,262 9.9% | 802,262 (New Position) | View |
2022-05-23 5:00 pm Purchase | 13G | VALLON PHARMACEUTICALS INC VLON | Lind Global Fund II LP | 1,084,500 9.9% | 1,084,500 (New Position) | View |
2022-04-29 4:31 pm Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | Lind Global Fund II LP | 2,969,718 5.3% | 2,969,718 (New Position) | View |
2022-04-20 5:11 pm Purchase | 13G | KINTARA THERAPEUTICS INC KTRA | Lind Global Fund II LP | 3,773,586 5.8% | 3,773,586 (New Position) | View |
2022-02-23 5:00 pm Purchase | 13G | CEA IND INC CEAD | Lind Global Fund II LP | 400,000 5.4% | 400,000 (New Position) | View |
2022-02-11 5:09 pm Sale | 13G | SUPERIOR DRILLING PRODS INC CO SDPI | Lind Global Fund II LP | 908,643 3.2% | -830,488 (-47.75%) | View |
2022-02-11 5:08 pm Sale | 13G | PEDEVCO CORP COM PAR .20 PED | Lind Global Fund II LP | 0 0% | -4,458,600 (Position Closed) | View |
2022-02-11 5:07 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 434,311 3.3% | 434,311 (New Position) | View |
2022-02-11 5:00 pm Purchase | 13G | REWALK ROBOTICS LTD SHARE LFWD | Lind Global Fund II LP | 7,238,134 11.4% | 3,953,362 (+120.35%) | View |
2022-01-21 5:01 pm Purchase | 13G | CHINA SXT PHARMACEUTICALS INC SXTC | Lind Global Fund II LP | 2,575,000 9.9% | 2,575,000 (New Position) | View |
2021-10-19 5:15 pm Purchase | 13G | SUPERIOR DRILLING PRODS INC CO SDPI | Lind Global Fund II LP | 1,739,131 6.3% | 1,739,131 (New Position) | View |
2021-10-06 5:11 pm Purchase | 13G | PEDEVCO CORP COM PAR .20 PED | Lind Global Fund II LP | 4,458,600 5.3% | 4,458,600 (New Position) | View |
2021-10-04 5:11 pm Purchase | 13G | REWALK ROBOTICS LTD SHARE LFWD | Lind Global Fund II LP | 3,284,772 5.3% | 3,284,772 (New Position) | View |
2021-08-20 4:45 pm Purchase | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Lind Global Fund II LP | 1,302,933 9.9% | 1,302,933 (New Position) | View |